United States Angina Pectoris Treatment Sales Market Report 2021

July 2016 | 104 pages | ID: U18A2199E2AEN
QYResearch

Abstracts

This report studies sales (consumption) of Angina Pectoris Treatment in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abbott Laboratories Inc.
• Astra Zeneca plc
• Bayer AG
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd
• Forest Laboratories Inc
• Gilead Sciences, Inc
• GlaxoSmithKline plc
• Novartis AG
• Pfizer Inc.
• Sanofi SA

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Antiplatelet agents
• Beta-adrenergic blocking agents
• Calcium channel blockers
• Short & Long – acting Nitroglycerines
• Angiotensin-converting enzyme (ACE) inhibitors
• Anti-ischemic agents

Split by applications, this report focuses on sales, market share and growth rate of Angina Pectoris Treatment in each application, can be divided into

• Hospitals
• Clinic
• Other

Contents

United States Angina Pectoris Treatment Sales Market Report 2021

1 ANGINA PECTORIS TREATMENT OVERVIEW

1.1 Product Overview and Scope of Angina Pectoris Treatment
1.2 Classification of Angina Pectoris Treatment
  1.2.1 Antiplatelet agents
  1.2.2 Beta-adrenergic blocking agents
  1.2.3 Calcium channel blockers
  1.2.4 Short & Long – acting Nitroglycerines
  1.2.5 Angiotensin-converting enzyme (ACE) inhibitors
  1.2.6 Anti-ischemic agents
1.3 Applications of Angina Pectoris Treatment
  1.3.1 Hospitals
  1.3.2 Clinic
  1.3.3 Other
1.4 USA Market Size (Value and Volume) of Angina Pectoris Treatment (2011-2021)
  1.4.1 USA Angina Pectoris Treatment Sales, Revenue and Price (2011-2021)
  1.4.2 USA Angina Pectoris Treatment Sales and Growth Rate (2011-2021)
  1.4.3 USA Angina Pectoris Treatment Revenue and Growth Rate (2011-2021)

2 USA ANGINA PECTORIS TREATMENT COMPETITION BY MANUFACTURERS

2.1 USA Angina Pectoris Treatment Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Angina Pectoris Treatment Revenue and Share by Manufactures (2015 and 2016)

3 USA ANGINA PECTORIS TREATMENT (VOLUME AND VALUE) BY TYPE

3.1 USA Angina Pectoris Treatment Sales and Market Share by Type (2011-2021)
3.2 USA Angina Pectoris Treatment Revenue and Market Share by Type (2011-2021)

4 USA ANGINA PECTORIS TREATMENT (VOLUME) BY APPLICATION

5 USA ANGINA PECTORIS TREATMENT MANUFACTURERS ANALYSIS

5.1 Abbott Laboratories Inc.
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Angina Pectoris Treatment Product Type and Technology
    5.1.2.1 Antiplatelet agents
    5.1.2.2 Beta-adrenergic blocking agents
  5.1.3 Angina Pectoris Treatment Sales, Revenue, Price of Abbott Laboratories Inc. (2015 and 2016)
5.2 Astra Zeneca plc
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Antiplatelet agents
    5.2.2.2 Beta-adrenergic blocking agents
  5.2.3 Pharmaceuticals Sales, Revenue, Price of Astra Zeneca plc (2015 and 2016)
5.3 Bayer AG
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Bayer AG Product Type and Technology
    5.3.2.1 Antiplatelet agents
    5.3.2.2 Beta-adrenergic blocking agents
  5.3.3 Bayer AG Sales, Revenue, Price of Bayer AG (2015 and 2016)
5.4 Bristol-Myers Squibb Company
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Novartis AG Product Type and Technology
    5.4.2.1 Antiplatelet agents
    5.4.2.2 Beta-adrenergic blocking agents
  5.4.3 Bristol-Myers Squibb Company Sales, Revenue, Price of Bristol-Myers Squibb Company (2015 and 2016)
5.5 F. Hoffmann-La Roche Ltd
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 F. Hoffmann-La Roche Ltd Product Type and Technology
    5.5.2.1 Antiplatelet agents
    5.5.2.2 Beta-adrenergic blocking agents
  5.5.3 F. Hoffmann-La Roche Ltd Sales, Revenue, Price of F. Hoffmann-La Roche Ltd (2015 and 2016)
5.6 Forest Laboratories Inc
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 Forest Laboratories Inc Product Type and Technology
    5.6.2.1 Antiplatelet agents
    5.6.2.2 Beta-adrenergic blocking agents
  5.6.3 Forest Laboratories Inc Sales, Revenue, Price of Forest Laboratories Inc (2015 and 2016)
5.7 Gilead Sciences, Inc
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 Gilead Sciences, Inc Product Type and Technology
    5.7.2.1 Antiplatelet agents
    5.7.2.2 Beta-adrenergic blocking agents
  5.7.3 Gilead Sciences, Inc Sales, Revenue, Price of Gilead Sciences, Inc (2015 and 2016)
5.8 GlaxoSmithKline plc
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 GlaxoSmithKline plc Product Type and Technology
    5.8.2.1 Antiplatelet agents
    5.8.2.2 Beta-adrenergic blocking agents
  5.8.3 GlaxoSmithKline plc Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
5.9 Novartis AG
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 Novartis AG Product Type and Technology
    5.9.2.1 Antiplatelet agents
    5.9.2.2 Beta-adrenergic blocking agents
  5.9.3 Novartis AG Sales, Revenue, Price of Novartis AG (2015 and 2016)
5.10 Pfizer Inc.
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Pfizer Inc. Product Type and Technology
    5.10.2.1 Antiplatelet agents
    5.10.2.2 Beta-adrenergic blocking agents
  5.10.3 Pfizer Inc. Sales, Revenue, Price of Pfizer Inc. (2015 and 2016)
5.11 Sanofi SA

6 ANGINA PECTORIS TREATMENT TECHNOLOGY AND DEVELOPMENT TREND

6.1 Angina Pectoris Treatment Technology Analysis
6.2 Angina Pectoris Treatment Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Angina Pectoris Treatment
Table Classification of Angina Pectoris Treatment
Figure USA Sales Market Share of Angina Pectoris Treatment by Type in 2015
Figure Antiplatelet agents Picture
Figure Beta-adrenergic blocking agents Picture
Figure Calcium channel blockers Picture
Figure Short & Long – acting Nitroglycerines Picture
Figure Angiotensin-converting enzyme (ACE) inhibitors Picture
Figure Anti-ischemic agents Picture
Table Applications of Angina Pectoris Treatment
Figure USA Sales Market Share of Angina Pectoris Treatment by Application in 2015
Figure Hospitals Examples
Figure Clinic Examples
Figure Other Examples
Table USA Angina Pectoris Treatment Sales, Revenue and Price (2011-2021)
Figure USA Angina Pectoris Treatment Sales and Growth Rate (2011-2021)
Figure USA Angina Pectoris Treatment Revenue and Growth Rate (2011-2021)
Table USA Angina Pectoris Treatment Sales of Key Manufacturers (2015 and 2016)
Table USA Angina Pectoris Treatment Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Angina Pectoris Treatment Sales Share by Manufacturers
Figure 2016 Angina Pectoris Treatment Sales Share by Manufacturers
Table USA Angina Pectoris Treatment Revenue by Manufacturers (2015 and 2016)
Table USA Angina Pectoris Treatment Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Angina Pectoris Treatment Revenue Share by Manufacturers
Table 2016 USA Angina Pectoris Treatment Revenue Share by Manufacturers
Table USA Angina Pectoris Treatment Sales and Market Share by Type (2011-2021)
Table USA Angina Pectoris Treatment Sales Share by Type (2011-2021)
Figure Sales Market Share of Angina Pectoris Treatment by Type (2011-2021)
Figure USA Angina Pectoris Treatment Sales Growth Rate by Type (2011-2021)
Table USA Angina Pectoris Treatment Revenue and Market Share by Type (2011-2021)
Table USA Angina Pectoris Treatment Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Angina Pectoris Treatment by Type (2011-2021)
Figure USA Angina Pectoris Treatment Revenue Growth Rate by Type (2011-2021)
Table USA Angina Pectoris Treatment Sales and Market Share by Application (2011-2021)
Table USA Angina Pectoris Treatment Sales Share by Application (2011-2021)
Figure Sales Market Share of Angina Pectoris Treatment by Application (2011-2021)
Figure USA Angina Pectoris Treatment Sales Growth Rate by Application (2011-2021)
Table Abbott Laboratories Inc. Basic Information List
Table Angina Pectoris Treatment Sales, Revenue, Price of Abbott Laboratories Inc. (2015 and 2016)
Table Astra Zeneca plc Basic Information List
Table Angina Pectoris Treatment Sales, Revenue, Price of Astra Zeneca plc (2015 and 2016)
Table Bayer AG Basic Information List
Table Angina Pectoris Treatment Sales, Revenue, Price of Bayer AG (2015 and 2016)
Table Bristol-Myers Squibb Company Basic Information List
Table Angina Pectoris Treatment Sales, Revenue, Price of Bristol-Myers Squibb Company (2015 and 2016)
Table F. Hoffmann-La Roche Ltd Basic Information List
Table Angina Pectoris Treatment Sales, Revenue, Price of F. Hoffmann-La Roche Ltd (2015 and 2016)
Table Forest Laboratories Inc Basic Information List
Table Angina Pectoris Treatment Sales, Revenue, Price of Forest Laboratories Inc (2015 and 2016)
Table Gilead Sciences, Inc Basic Information List
Table Angina Pectoris Treatment Sales, Revenue, Price of Gilead Sciences, Inc (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Angina Pectoris Treatment Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Novartis AG Basic Information List
Table Angina Pectoris Treatment Sales, Revenue, Price of Novartis AG (2015 and 2016)
Table Pfizer Inc. Basic Information List
Table Angina Pectoris Treatment Sales, Revenue, Price of Pfizer Inc. (2015 and 2016)
Table Sanofi SA Basic Information List
Table Angina Pectoris Treatment Sales, Revenue, Price of Sanofi SA (2015 and 2016)